Noncompaction cardiomyopathy laboratory studies

Noncompaction Cardiomyopathy Microchapters
Home
Patient Info
Overview
Historical Perspective
Classification & Nomenclature
Pathophysiology
Genetics
Embryology
Histology
Left Ventricular Dysfunction
Arrhythmias
Thromboembolism
Neuromuscular Disorders
Epidemiology & Demographics
Screening
Natural History, Complications & Prognosis
Differentiating Noncompaction Cardiomyopathy from other Diseases
Diagnosis
History & Symptoms
Physical Examination
Laboratory Studies
Genetic Testing
Electrocardiogram
Holter Monitoring
Chest X Ray
MRI
CT
Echocardiography
Biopsy
Treatment
Medical Therapy
Surgery
Noncompaction cardiomyopathy laboratory studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Noncompaction cardiomyopathy laboratory studies
CDC on Noncompaction cardiomyopathy laboratory studies
Noncompaction cardiomyopathy laboratory studies in the news
Blogs on Noncompaction cardiomyopathy laboratory studies
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Noncompaction cardiomyopathy laboratory studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Consideration should be given to testing for the presence of Barth Syndrome which includes the following :

• Neutropenia
• 3-methylgluconic aciduria